Organovo Holdings, Inc.
ONVO
Rank in Stocks
#36036
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
Share Price
$2.00
Last synced: 2025-05-19
Market Cap
$2.93M
Change (1 day)
-3.38%
Change (1 year)
656.14%
Country
US
Trade Organovo Holdings, Inc. (ONVO)
Category
Healthcare
Stock price history for Organovo Holdings, Inc. (ONVO)
Highest end of day price: $5.13 on 2025-03-01
Lowest end of day price: $131.45 on 2014-11-01
Lowest end of day price: $131.45 on 2014-11-01
Stock price history of Organovo Holdings, Inc. from 2014 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2025 | 6.61% |
| 2024 | -65.68% |
| 2023 | -24.35% |
| 2022 | -61.52% |
| 2021 | -70.29% |
| 2020 | -31.30% |
| 2019 | -29.19% |
| 2018 | 153.68% |
| 2014 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $137.75 | -3.72% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
